Impact of the FDA's Move on Painkillers Merck and Pfizer's stocks barely budged Thursday after news that the Food and Drug Administration had asked for the removal of Bextra from the market and plans to beef up warnings on certain drug labels. Both companies have had to deal with the financial ramifications of concerns over painkillers.
NPR logo

Impact of the FDA's Move on Painkillers

  • Download
  • <iframe src="https://www.npr.org/player/embed/4581530/4581531" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Impact of the FDA's Move on Painkillers

Impact of the FDA's Move on Painkillers

Impact of the FDA's Move on Painkillers

  • Download
  • <iframe src="https://www.npr.org/player/embed/4581530/4581531" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Merck and Pfizer's stocks barely budged Thursday after news that the Food and Drug Administration had asked for the removal of Bextra from the market and plans to beef up warnings on certain drug labels. Both companies have had to deal with the financial ramifications of concerns over painkillers.